SPC457
Gefapixant og lyfjafræðilega viðunandi sölt þar af
Status:
VeittApplication date:
5.3.2024Application published:
15.4.2024Grant published:
15.11.2025
Max expiry date:
19.9.2038Medicine name:
LyfnuaMedicine for children:
No
Timeline
Today
5.3.2024Application
15.4.2024Publication
15.11.2025Registration
19.9.2038Expires
Marketing license
IS authorization number:
EU/1/21/1613Date:
19.10.2023
Foreign authorization number:
EU/1/21/1613Date:
15.9.2023
Owner
Name:
Afferent Pharmaceuticals Inc.Address:
126 East Lincoln Avenue Rahway, New Jersey 07065 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3355889
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 12.10.2025